ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates
MHRA Drug Safety Updates

 

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA October 2021-PDF.pdf

Drug Safety Update MHRA October 2021-PDF.pdf
Summary: Tofacitinib (Xeljanzâ–Ľ): new measures to minimise risk of major adverse cardiovascular events and malignancies page 2 Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication page 6 MedSafetyWeek November 2021: support the safety of vaccines page 9 COVID-19 vaccines: updates for October 2021
File Size: 287KB
File Type: application/pdf
Created: 07 October 2021
Last Modified: 17 November 2021